Capogrossi MC - Search Results

1

Intracellular targets of RGDS peptide in melanoma cells.

Aguzzi MS, Fortugno P, Giampietri C, Ragone G, Capogrossi MC, Facchiano A. Aguzzi MS, et al. Among authors: capogrossi mc. Mol Cancer. 2010 Apr 22;9:84. doi: 10.1186/1476-4598-9-84. Mol Cancer. 2010. PMID: 20412563 Free PMC article.

2

RGDS peptide induces caspase 8 and caspase 9 activation in human endothelial cells.

Aguzzi MS, Giampietri C, De Marchis F, Padula F, Gaeta R, Ragone G, Capogrossi MC, Facchiano A. Aguzzi MS, et al. Among authors: capogrossi mc. Blood. 2004 Jun 1;103(11):4180-7. doi: 10.1182/blood-2003-06-2144. Epub 2004 Feb 24. Blood. 2004. PMID: 14982875 Free article.

3

The FGF-2-derived peptide FREG inhibits melanoma growth in vitro and in vivo.

Aguzzi MS, Faraone D, D'Arcangelo D, De Marchis F, Toietta G, Ribatti D, Parazzoli A, Colombo P, Capogrossi MC, Facchiano A. Aguzzi MS, et al. Among authors: capogrossi mc. Mol Ther. 2011 Feb;19(2):266-73. doi: 10.1038/mt.2010.211. Epub 2010 Oct 5. Mol Ther. 2011. PMID: 20924364 Free PMC article.

4

RAM, an RGDS analog, exerts potent anti-melanoma effects in vitro and in vivo.

Aguzzi MS, D'Arcangelo D, Giampietri C, Capogrossi MC, Facchiano A. Aguzzi MS, et al. Among authors: capogrossi mc. PLoS One. 2011;6(10):e25352. doi: 10.1371/journal.pone.0025352. Epub 2011 Oct 3. PLoS One. 2011. PMID: 21984914 Free PMC article.

5

Identification of a novel domain of fibroblast growth factor 2 controlling its angiogenic properties.

Facchiano A, Russo K, Facchiano AM, De Marchis F, Facchiano F, Ribatti D, Aguzzi MS, Capogrossi MC. Facchiano A, et al. Among authors: capogrossi mc. J Biol Chem. 2003 Mar 7;278(10):8751-60. doi: 10.1074/jbc.M209936200. Epub 2002 Dec 20. J Biol Chem. 2003. PMID: 12496262 Free article.

6

RGDS peptide inhibits activation of lymphocytes and adhesion of activated lymphocytes to human umbilical vein endothelial cells in vitro.

Pozzetto U, Aguzzi MS, Maggiano N, Scala E, Capelli A, Castagneto M, Capogrossi MC, Citterio F, Serino F, Facchiano A. Pozzetto U, et al. Among authors: capogrossi mc. Immunol Cell Biol. 2005 Feb;83(1):25-32. doi: 10.1111/j.1440-1711.2004.01300.x. Immunol Cell Biol. 2005. PMID: 15661038

7

Heterodimerization of FGF-receptor 1 and PDGF-receptor-alpha: a novel mechanism underlying the inhibitory effect of PDGF-BB on FGF-2 in human cells.

Faraone D, Aguzzi MS, Ragone G, Russo K, Capogrossi MC, Facchiano A. Faraone D, et al. Among authors: capogrossi mc. Blood. 2006 Mar 1;107(5):1896-902. doi: 10.1182/blood-2005-04-1524. Epub 2005 Dec 1. Blood. 2006. PMID: 16322476 Free article.

8

Thrombin-mediated impairment of fibroblast growth factor-2 activity.

Totta P, De Cristofaro R, Giampietri C, Aguzzi MS, Faraone D, Capogrossi MC, Facchiano A. Totta P, et al. Among authors: capogrossi mc. FEBS J. 2009 Jun;276(12):3277-89. doi: 10.1111/j.1742-4658.2009.07042.x. Epub 2009 Apr 25. FEBS J. 2009. PMID: 19438723 Free article.

9

Platelet-derived growth factor-receptor alpha strongly inhibits melanoma growth in vitro and in vivo.

Faraone D, Aguzzi MS, Toietta G, Facchiano AM, Facchiano F, Magenta A, Martelli F, Truffa S, Cesareo E, Ribatti D, Capogrossi MC, Facchiano A. Faraone D, et al. Among authors: capogrossi mc. Neoplasia. 2009 Aug;11(8):732-42. doi: 10.1593/neo.09408. Neoplasia. 2009. PMID: 19649203 Free PMC article.

10

A novel RGDS-analog inhibits angiogenesis in vitro and in vivo.

Aguzzi MS, Facchiano F, Ribatti D, Gaeta R, Casadio R, Rossi I, Capogrossi MC, Facchiano A. Aguzzi MS, et al. Among authors: capogrossi mc. Biochem Biophys Res Commun. 2004 Sep 3;321(4):809-14. doi: 10.1016/j.bbrc.2004.07.036. Biochem Biophys Res Commun. 2004. PMID: 15358099

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

327 results

Search Page